SC 13G Filing

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

July 13, 2010

Accession Number

0001144204-10-037617

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →